This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ogasawara, K. Articles by Yoshimoto, T. Search for Related Content PubMed PubMed Citation Articles by Ogasawara, K. Articles by Yoshimoto, T. Related Collections Brain Circulation and Metabolism PET and SPECT Risk Factors for Stroke

(Stroke. 2002;33:1857.)
© 2002 American Heart Association, Inc.

Original Contributions

Cerebrovascular Reactivity to Acetazolamide and Outcome in Patients With Symptomatic Internal Carotid or Middle Cerebral Artery Occlusion

A Xenon-133 Single-Photon Emission Computed Tomography Study

Kuniaki Ogasawara, MD; Akira Ogawa, MD Takashi Yoshimoto, MD

From the Department of Neurosurgery and Cyclotron Research Center, Iwate Medical University (K.O., A.O.), Morioka, and Department of Neurosurgery, Tohoku University School of Medicine (T.Y.), Sendai, Japan.

Correspondence to Kuniaki Ogasawara, MD, Department of Neurosurgery, Iwate Medical University, 19-1 Uchimaru, Morioka 020-8505, Japan. E-mail kuogasa{at}iwate-med.ac.jp

Background and Purpose— The present study prospectively evaluated relationships among baseline characteristics, cerebral hemodynamics, and outcome of patients with symptomatic major cerebral artery occlusion, by quantitative measurement of cerebral blood flow using xenon-133 (¹³³Xe) inhalation and single-photon emission computed tomography (SPECT).

Methods— Regional cerebrovascular reactivity (rCVR) to acetazolamide was calculated at entry to the study using ¹³³Xe SPECT. Seventy consecutive patients aged less than 70 years with unilateral internal carotid artery (ICA) or middle cerebral artery (MCA) occlusion were divided into 2 groups: normal or reduced rCVR, and prospectively followed up for a period of 24 months.

Results— During the follow-up period, recurrent strokes occurred in 8 of the 23 patients with reduced rCVR at entry and in 3 of 47 patients with normal rCVR. Cumulative recurrence-free survival rates in all patients, and in each subgroup of patients with ICA or MCA occlusion and reduced rCVR on entry, were significantly lower than in those with normal rCVR (P=0.0030, P=0.0404, and P=0.0310, respectively; Kaplan-Meier analysis). Among the factors considered, only lower rCVR and resting regional cerebral blood flow values were significantly associated with the risk of stroke recurrence (P=0.0019 and P=0.0080, respectively; Cox regression multivariate analysis).

Conclusions— The present study demonstrated that reduced rCVR to acetazolamide as determined by ¹³³Xe SPECT is significantly associated with an increased risk of stroke recurrence in patients with symptomatic MCA or ICA occlusion.

Key Words: acetazolamide • cerebral artery occlusion • recurrence • tomography, emission computed

This article has been cited by other articles:

				R. Hirooka, K. Ogasawara, T. Inoue, S. Fujiwara, M. Sasaki, K. Chida, D. Ishigaki, M. Kobayashi, H. Nishimoto, Y. Otawara, et al. Simple Assessment of Cerebral Hemodynamics Using Single-Slab 3D Time-of-Flight MR Angiography in Patients with Cervical Internal Carotid Artery Steno-Occlusive Diseases: Comparison with Quantitative Perfusion Single-Photon Emission CT AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 559 - 563. [Abstract] [Full Text] [PDF]

				M. Hokari, S. Kuroda, T. Shiga, N. Nakayama, N. Tamaki, and Y. Iwasaki Combination of a Mean Transit Time Measurement with an Acetazolamide Test Increases Predictive Power to Identify Elevated Oxygen Extraction Fraction in Occlusive Carotid Artery Diseases J. Nucl. Med., December 1, 2008; 49(12): 1922 - 1927. [Abstract] [Full Text] [PDF]

				M. Tanaka, E. Shimosegawa, K. Kajimoto, Y. Kimura, H. Kato, N. Oku, M. Hori, K. Kitagawa, and J. Hatazawa Chronic Middle Cerebral Artery Occlusion: A Hemodynamic and Metabolic Study with Positron-Emission Tomography AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1841 - 1846. [Abstract] [Full Text] [PDF]

				N.-J. Rim, H.S. Kim, Y.S. Shin, and S.Y. Kim Which CT Perfusion Parameter Best Reflects Cerebrovascular Reserve?: Correlation of Acetazolamide-Challenged CT Perfusion with Single-Photon Emission CT in Moyamoya Patients AJNR Am. J. Neuroradiol., October 1, 2008; 29(9): 1658 - 1663. [Abstract] [Full Text] [PDF]

				M. Zhao, S. Amin-Hanjani, S. Ruland, A.P. Curcio, L. Ostergren, and F.T. Charbel Regional Cerebral Blood Flow Using Quantitative MR Angiography AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1470 - 1473. [Abstract] [Full Text] [PDF]

				S. Kuroda, N. Hashimoto, T. Yoshimoto, Y. Iwasaki, and for the Research Committee on Moyamoya Disease in Radiological Findings, Clinical Course, and Outcome in Asymptomatic Moyamoya Disease: Results of Multicenter Survey in Japan Stroke, May 1, 2007; 38(5): 1430 - 1435. [Abstract] [Full Text] [PDF]

				I. Uzunca, T. Asil, K. Balci, and U. Utku Evaluation of Vasomotor Reactivity by Transcranial Doppler Sonography in Patients With Acute Stroke Who Have Symptomatic Intracranial and Extracranial Stenosis J. Ultrasound Med., February 1, 2007; 26(2): 179 - 185. [Abstract] [Full Text] [PDF]

				C. L. Hallemeier, K. M. Rich, R. L. Grubb Jr, M. R. Chicoine, C. J. Moran, D. T. Cross III, G. J. Zipfel, R. G. Dacey Jr, and C. P. Derdeyn Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon Stroke, June 1, 2006; 37(6): 1490 - 1496. [Abstract] [Full Text] [PDF]

				H. Endo, T. Inoue, K. Ogasawara, T. Fukuda, Y. Kanbara, and A. Ogawa Quantitative Assessment of Cerebral Hemodynamics Using Perfusion-Weighted MRI in Patients With Major Cerebral Artery Occlusive Disease: Comparison With Positron Emission Tomography Stroke, February 1, 2006; 37(2): 388 - 392. [Abstract] [Full Text] [PDF]

				S. Kuroda, T. Shiga, K. Houkin, T. Ishikawa, C. Katoh, N. Tamaki, and Y. Iwasaki Cerebral Oxygen Metabolism and Neuronal Integrity in Patients With Impaired Vasoreactivity Attributable to Occlusive Carotid Artery Disease Stroke, February 1, 2006; 37(2): 393 - 398. [Abstract] [Full Text] [PDF]

				S. Amin-Hanjani, X. Du, M. Zhao, K. Walsh, T. W. Malisch, and F. T. Charbel Use of Quantitative Magnetic Resonance Angiography to Stratify Stroke Risk in Symptomatic Vertebrobasilar Disease Stroke, June 1, 2005; 36(6): 1140 - 1145. [Abstract] [Full Text] [PDF]

				K. Kario, J. Ishikawa, S. Hoshide, Y. Matsui, M. Morinari, K. Eguchi, S. Ishikawa, and K. Shimada Diabetic Brain Damage in Hypertension: Role of Renin-Angiotensin System Hypertension, May 1, 2005; 45(5): 887 - 893. [Abstract] [Full Text] [PDF]

				H. Adams, R. Adams, G. Del Zoppo, and L. B. Goldstein Guidelines for the Early Management of Patients With Ischemic Stroke: 2005 Guidelines Update A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association Stroke, April 1, 2005; 36(4): 916 - 923. [Full Text] [PDF]

				I. Momjian-Mayor and J.-C. Baron The Pathophysiology of Watershed Infarction in Internal Carotid Artery Disease: Review of Cerebral Perfusion Studies Stroke, March 1, 2005; 36(3): 567 - 577. [Abstract] [Full Text] [PDF]

				M. Kamouchi, K. Kishikawa, Y. Okada, T. Inoue, S. Ibayashi, and M. Iida Poststenotic Flow and Intracranial Hemodynamics in Patients with Carotid Stenosis: Transoral Carotid Ultrasonography Study AJNR Am. J. Neuroradiol., January 1, 2005; 26(1): 76 - 81. [Abstract] [Full Text] [PDF]

				J-C Baron Using PET to identify carotid occlusion patients at high risk of subsequent stroke: further insights J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1659 - 1660. [Full Text] [PDF]

				J. Hendrikse, M. J. P. van Osch, D. R. Rutgers, C. J. G. Bakker, L. J. Kappelle, X. Golay, and J. van der Grond Internal Carotid Artery Occlusion Assessed at Pulsed Arterial Spin-labeling Perfusion MR Imaging at Multiple Delay Times Radiology, December 1, 2004; 233(3): 899 - 904. [Abstract] [Full Text] [PDF]

				S. Kuroda, T. Shiga, T. Ishikawa, K. Houkin, T. Narita, C. Katoh, N. Tamaki, and Y. Iwasaki Reduced Blood Flow and Preserved Vasoreactivity Characterize Oxygen Hypometabolism Due to Incomplete Infarction in Occlusive Carotid Artery Diseases J. Nucl. Med., June 1, 2004; 45(6): 943 - 949. [Abstract] [Full Text] [PDF]

				M. J. de Boorder, J. Hendrikse, and J. van der Grond Phase-Contrast Magnetic Resonance Imaging Measurements of Cerebral Autoregulation With a Breath-Hold Challenge: A Feasibility Study Stroke, June 1, 2004; 35(6): 1350 - 1354. [Abstract] [Full Text] [PDF]

				P. H. Lee, S. -H. Oh, O. Y. Bang, S. -Y. Joo, I. S. Joo, and K. Huh Infarct patterns in atherosclerotic middle cerebral artery versus internal carotid artery disease Neurology, April 27, 2004; 62(8): 1291 - 1296. [Abstract] [Full Text] [PDF]

				C. P Derdeyn Cerebral Hemodynamics in Carotid Occlusive Disease AJNR Am. J. Neuroradiol., September 1, 2003; 24(8): 1497 - 1499. [Full Text] [PDF]

				K. Ogasawara, T. Okuguchi, M. Sasoh, M. Kobayashi, H. Yukawa, K. Terasaki, T. Inoue, and A. Ogawa Qualitative versus Quantitative Assessment of Cerebrovascular Reactivity to Acetazolamide Using iodine-123-N-Isopropyl-p-Iodoamphetamine SPECT in Patients with Unilateral Major Cerebral Artery Occlusive Disease AJNR Am. J. Neuroradiol., June 1, 2003; 24(6): 1090 - 1095. [Abstract] [Full Text] [PDF]

				K. Ogasawara, H. Ito, M. Sasoh, T. Okuguchi, M. Kobayashi, H. Yukawa, K. Terasaki, and A. Ogawa Quantitative Measurement of Regional Cerebrovascular Reactivity to Acetazolamide Using 123I-N-Isopropyl-p-Iodoamphetamine Autoradiography with SPECT: Validation Study Using H215O with PET J. Nucl. Med., April 1, 2003; 44(4): 520 - 525. [Abstract] [Full Text] [PDF]